Denali Therapeutics
DNLI
DNLI
148 hedge funds and large institutions have $2B invested in Denali Therapeutics in 2020 Q2 according to their latest regulatory filings, with 32 funds opening new positions, 54 increasing their positions, 37 reducing their positions, and 11 closing their positions.
New
Increased
Maintained
Reduced
Closed
more first-time investments, than exits
New positions opened: | Existing positions closed:
more call options, than puts
Call options by funds: $ | Put options by funds: $
more repeat investments, than reductions
Existing positions increased: | Existing positions reduced:
more capital invested
Capital invested by funds: $ → $
16% more funds holding
Funds holding: 128 → 148 (+20)
2.02% more ownership
Funds ownership: 76.34% → 78.36% (+2%)
25% less funds holding in top 10
Funds holding in top 10: 4 → 3 (-1)
Holders
148
Holding in Top 10
3
Calls
$837K
Puts
$324K
Top Buyers
| 1 | +$34.1M | |
| 2 | +$24M | |
| 3 | +$13.4M | |
| 4 |
CCM
CAAS Capital Management
New York
|
+$12.7M |
| 5 |
UBS AM
Chicago,
Illinois
|
+$10.3M |
Top Sellers
| 1 | -$46.5M | |
| 2 | -$14.9M | |
| 3 | -$12.2M | |
| 4 |
Fidelity Investments
Boston,
Massachusetts
|
-$9.95M |
| 5 |
MWNA
Marshall Wace North America
New York
|
-$7.82M |